The Impact of COVID-19 is included in Dry Age Related Macular Degeneration Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Dry Age Related Macular Degeneration Trends and Forecast
The future of the global dry age related macular degeneration market looks promising with opportunities in the hospitals & clinics, diagnostic centers, and academic & research institutes markets. The global dry age related macular degeneration market is expected to grow with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are rising elderly populations and growing incidence of age-related macular degeneration.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Dry Age Related Macular Degeneration by Segment
The study includes a forecast for the global dry age related macular degeneration by age group, diagnosis & treatment, route of administration, end use industry, and region.
Dry Age Related Macular Degeneration Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:
• Above 75 Years
• Above 60 Years
• Above 40 Years
Dry Age Related Macular Degeneration Market by Diagnosis & Treatment [Shipment Analysis by Value from 2018 to 2030]:
• Treatment
• Diagnosis
Dry Age Related Macular Degeneration Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:
• Oral
• Injectables
Dry Age Related Macular Degeneration Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals & Clinics
• Diagnostic Centers
• Academic & Research Institutes
• Others
Dry Age Related Macular Degeneration Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Dry Age Related Macular Degeneration Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies dry age related macular degeneration companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the dry age related macular degeneration companies profiled in this report include-
• Santen Pharmaceuticals
• Allergan
• Bausch Health
• Alimera Science
• Phio Pharmaceuticals
• Ocumension Therapeutics
• Belite Bio
• Kubota Vision
• Iveric Bio
• Eyestem Research
Dry Age Related Macular Degeneration Market Insights
Lucintel forecasts that above 75 years is expected to witness largest growth over the forecast period due to rising population of senior patients.
Within this market, hospitals & clinics will remain the largest segment due to the installation of advanced and comprehensive treatment facilities in hospitals.
North America is expected to witness highest growth over the forecast period due to government initiatives and financial support are further driving the expansion of this market in this region.
Features of the Global Dry Age Related Macular Degeneration Market
Market Size Estimates: Dry age related macular degeneration market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Dry age related macular degeneration market size by various segments, such as by age group, diagnosis & treatment, route of administration, end use industry, and region in terms of value ($B).
Regional Analysis: Dry age related macular degeneration market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different age group, diagnosis & treatment, route of administration, end use industry, and regions for the dry age related macular degeneration market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the dry age related macular degeneration market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for dry age related macular degeneration market?
Answer: The global dry age related macular degeneration market is expected to grow with a CAGR of 7.1% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the dry age related macular degeneration market?
Answer: The major drivers for this market are rising elderly populations and growing incidence of age-related macular degeneration.
Q3. What are the major segments for dry age related macular degeneration market?
Answer: The future of the dry age related macular degeneration market looks promising with opportunities in the hospitals & clinics, diagnostic centers, and academic & research institutes markets.
Q4. Who are the key dry age related macular degeneration market companies?
Answer: Some of the key dry age related macular degeneration companies are as follows:
• Santen Pharmaceuticals
• Allergan
• Bausch Health
• Alimera Science
• Phio Pharmaceuticals
• Ocumension Therapeutics
• Belite Bio
• Kubota Vision
• Iveric Bio
• Eyestem Research
Q5. Which dry age related macular degeneration market segment will be the largest in future?
Answer: Lucintel forecasts that above 75 years is expected to witness largest growth over the forecast period due to rising population of senior patients.
Q6. In dry age related macular degeneration market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to government initiatives and financial support are further driving the expansion of this market in this region.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the dry age related macular degeneration market by age group (above 75 years, above 60 years, and above 40 years), diagnosis & treatment (treatment and diagnosis), route of administration (oral and injectables), end use industry (hospitals & clinics, diagnostic centers, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Dry Age Related Macular Degeneration Market, Dry Age Related Macular Degeneration Market Size, Dry Age Related Macular Degeneration Market Growth, Dry Age Related Macular Degeneration Market Analysis, Dry Age Related Macular Degeneration Market Report, Dry Age Related Macular Degeneration Market Share, Dry Age Related Macular Degeneration Market Trends, Dry Age Related Macular Degeneration Market Forecast, Dry Age Related Macular Degeneration Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Dry Age Related Macular Degeneration Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Dry Age Related Macular Degeneration Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Dry Age Related Macular Degeneration Market by Age Group
3.3.1: Above 75 Years
3.3.2: Above 60 Years
3.3.3: Above 40 Years
3.4: Global Dry Age Related Macular Degeneration Market by Diagnosis & Treatment
3.4.1: Treatment
3.4.2: Diagnosis
3.5: Global Dry Age Related Macular Degeneration Market by Route of Administration
3.5.1: Oral
3.5.2: Injectables
3.6: Global Dry Age Related Macular Degeneration Market by End Use Industry
3.6.1: Hospitals & Clinics
3.6.2: Diagnostic Centers
3.6.3: Academic & Research Institutes
3.6.4: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Dry Age Related Macular Degeneration Market by Region
4.2: North American Dry Age Related Macular Degeneration Market
4.2.2: North American Dry Age Related Macular Degeneration Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
4.3: European Dry Age Related Macular Degeneration Market
4.3.1: European Dry Age Related Macular Degeneration Market by Age Group: Above 75 Years, Above 60 Years, and Above 40 Years
4.3.2: European Dry Age Related Macular Degeneration Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
4.4: APAC Dry Age Related Macular Degeneration Market
4.4.1: APAC Dry Age Related Macular Degeneration Market by Age Group: Above 75 Years, Above 60 Years, and Above 40 Years
4.4.2: APAC Dry Age Related Macular Degeneration Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
4.5: ROW Dry Age Related Macular Degeneration Market
4.5.1: ROW Dry Age Related Macular Degeneration Market by Age Group: Above 75 Years, Above 60 Years, and Above 40 Years
4.5.2: ROW Dry Age Related Macular Degeneration Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Dry Age Related Macular Degeneration Market by Age Group
6.1.2: Growth Opportunities for the Global Dry Age Related Macular Degeneration Market by Diagnosis & Treatment
6.1.3: Growth Opportunities for the Global Dry Age Related Macular Degeneration Market by Route of Administration
6.1.4: Growth Opportunities for the Global Dry Age Related Macular Degeneration Market by End Use Industry
6.1.5: Growth Opportunities for the Global Dry Age Related Macular Degeneration Market by Region
6.2: Emerging Trends in the Global Dry Age Related Macular Degeneration Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Dry Age Related Macular Degeneration Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Dry Age Related Macular Degeneration Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Santen Pharmaceuticals
7.2: Allergan
7.3: Bausch Health
7.4: Alimera Science
7.5: Phio Pharmaceuticals
7.6: Ocumension Therapeutics
7.7: Belite Bio
7.8: Kubota Vision
7.9: Iveric Bio
7.10: Eyestem Research
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Dry Age Related Macular Degeneration Market Report.